1) |
CONTROL |
Vehicle solution (saline) was injected intraperitoneally for 7 consecutive days |
10 |
2) |
CONTROL +PF-475 2.5 mg/kg |
PF-475 2.5 mg/kg was administered intraperitoneally for 7 consecutive days starting 24 h after vehicle solution injection |
10 |
3) |
CONTROL + PF-475 5 mg/kg |
PF-475 5 mg/kg was administered intraperitoneally for 7 consecutive days starting 24 h after vehicle solution injection |
10 |
4) |
CONTROL + PF-475 10 mg/kg |
PF-475 10 mg/kg was administered intraperitoneally for 7 consecutive days starting 24 h after vehicle solution injection |
10 |
5) |
MPTP |
MPTP solution was administered intraperitoneally during the first day, and saline intraperitoneal administration for 7 consecutive days starting 24 h after MPTP injection. |
10 |
6) |
MPTP + PF-475 2.5 mg/kg |
MPTP solution was administered intraperitoneally during the first day, and PF-475 2.5 mg/kg intraperitoneal administration for 7 consecutive days starting 24 h after MPTP injection. |
10 |
7) |
MPTP + PF-475 5 mg/kg |
MPTP solution was administered intraperitoneally during the first day, and PF-475 5 mg/kg intraperitoneal administration for 7 consecutive days starting 24 h after MPTP injection. |
10 |
8) |
MPTP + PF-475 10 mg/kg |
MPTP solution was administered intraperitoneally during the first day, and PF-475 10 mg/kg intraperitoneal administration for 7 consecutive days starting 24 h after MPTP injection. |
10 |